• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Medical School Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Medical School Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home Uncategorized

Mindfulness-based therapy associated with improvement in quality of life for PTSD patients

byJohn PrendergassandPriyanka Vedak
August 5, 2015
in Uncategorized
Reading Time: 3 mins read
Mindfulness-based therapy associated with improvement in quality of life for PTSD patients
Share on FacebookShare on TwitterShare on LinkedIn

1. In this study, mindfulness-based stress reduction (MBSR) therapy resulted in a greater reduction in self-reported post-traumatic stress disorder (PTSD) symptoms and improved quality of life compared to present-centered therapy (PCT).

2. There was no significant difference in PTSD diagnosis status after treatment or at 2-month follow-up between the two groups.

Evidence Rating Level: 1(Excellent)

Study Rundown: Post-traumatic stress disorder (PTSD) is triggered by life-threating events, with subsequent symptoms including nightmares, intrusive memories, emotional distress, feelings of numbness, and hopelessness, among others. Individuals with PTSD are at a greater risk of suicide, depression, and substance use disorders. Current treatment options for PTSD include cognitive therapy, exposure therapy, antidepressants, and anti-anxiety medications. Two additional options for treatment are mindfulness-based stress reduction (MBSR) and present-centered therapy (PCT). While the former option teaches meditation practices to the individual, the latter emphasizes the individual’s existing strengths in order to cope with stressors. The authors of this study compared these two methods as treatment options for PTSD in a randomized controlled trial.

The authors of this study found that MBSR resulted in a greater reduction in self-reported PTSD symptoms at 2-month follow-up as well as an improved quality of life when compared to PCT. There was no significant difference however in the rates of self-reported depressive symptoms or PTSD diagnosis status observed between the two groups. While this study was strengthened by its randomized controlled trial design, it was limited by the short follow-up period of 2 months, restricting our understanding of either treatment’s long-term effects. Due to inherent differences in the amount of contact required for either type of treatment (2.5 hour group sessions for MBSR and 1.5 hour group sessions for PCT), individuals in the active arm of this study received more clinician interaction than those in the control arm, potentially confounding results. Nevertheless, treatments such as MBSR may expand the therapeutic options available for PTSD. Future studies in this area should focus on further validation of such alternative PTSD treatments, particularly through long-term follow-up studies.

Click to read the study, published today in JAMA

RELATED REPORTS

Pennsylvania reports 1,260 measles cases across 43 counties in 2026

Zanidatamab-hrii combinations improved survival in first-line HER2-positive advanced gastroesophageal adenocarcinoma

Click to read the accompanying editorial in JAMA

Relevant Reading: Meditation programs for psychological stress and well-being

In-Depth [randomized controlled trial]: This study evaluated 116 veterans with PTSD from the Minneapolis Veterans Affairs Medical Center between March 2012 and December 2013. Inclusion criteria were that veterans met a diagnosis of full or subthreshold PTSD per DSM-IV criteria, participated in no other PTSD psychotherapy during the study period, and received either no medications or were on a stable medication regimen. MBSR resulted in a greater reduction in self-reported PTSD symptoms according to the PTSD checklist at post-treatment and at 2-month follow-up from scores of 63.6 to 55.7 and then 54.4 vs. PCT, from 58.8 to 55.8 and then 56.0 (p = 0.002 and p 0<0.001, respectively). MBSR participants reported greater improvement in quality of life from baseline to 2-month follow-up than did those in PCT (mean score improvement MBSR from 75.6 to 80.2 vs. PCT from 76.4 to 75.8; mean difference in improvement 5.22, 95%CI 1.73-8.71). Differences between the two groups for change in PTSD diagnosis status after treatment and at 2 months follow-up between the two groups were not significant (42.3% and 53.3% loss of diagnosis of PTSD with MBSR, respectively; and 43.9% and 47.3% loss of diagnosis of PTSD with PCT, respectively).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

Vitamin D supplementation amongst post-menopausal women did not improve functional outcomes

Next Post

Even low levels of physical activity reduce mortality in elderly

RelatedReports

An illustration depicting two syringes near a stylized representation of a human arm, symbolizing the administration of flu and COVID-19 vaccinations.
2MM Trial Briefs

Pennsylvania reports 1,260 measles cases across 43 counties in 2026

October 27, 2026
A sleeping patient in a hospital bed with an IV drip, a clock showing time, and light shining from a lamp, suggesting themes of sleep, time, and chemotherapy treatment.
2MM Trial Briefs

Zanidatamab-hrii combinations improved survival in first-line HER2-positive advanced gastroesophageal adenocarcinoma

October 27, 2026
A patient undergoing dialysis while using a pedaling device for exercise.
2MM Trial Briefs

Upacicalcet reduced parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism in PATH-1 and PATH-2

October 27, 2026
An envelope is being held with a calendar and an illustration of the colon in the background, indicating a reminder for colorectal screening.
2MM Trial Briefs

WGS Oncodetect showed higher recurrence sensitivity than WES Oncodetect in colorectal cancer

October 26, 2026
Next Post
Physical therapy for hip osteoarthritis may not lead to significant benefits

Even low levels of physical activity reduce mortality in elderly

Repeat Transrectal Prostate Biopsies May Increase Infection Risk

Combination of early docetaxel therapy linked to increased survival in metastatic prostate cancer patients

2 Minute Medicine Rewind January 13-19, 2014

Topical intracoital tenofovir gel linked to decreased incidence of herpes simplex virus type 2

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Pennsylvania reports 1,260 measles cases across 43 counties in 2026
  • Zanidatamab-hrii combinations improved survival in first-line HER2-positive advanced gastroesophageal adenocarcinoma
  • Upacicalcet reduced parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism in PATH-1 and PATH-2
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Medical School Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.